Substrate
science

U.S. Space Force Awards SpaceX $2.29 Billion Contract

The U.S. Space Force has awarded SpaceX a $2.29 billion contract to develop a space-based military data network. Multiple outlets reported the same contract value and purpose.

DE
KO
DI
WA
IN
5 sources·May 27, 10:34 AM(2 days ago)·1m read
|
U.S. Space Force Awards SpaceX $2.29 Billion Contractthestreet.com
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

S. 29 billion contract to develop a space-based military data network. The contract covers development of the network for military use.

The award was announced on the current date.

Several financial and news accounts published identical figures for the contract value. The network is described as a space data system intended for military communications.

Company and Agency Involved SpaceX is the recipient of the contract. The U.S.

Space Force is the awarding agency. No additional contract milestones or timelines were specified in the reports.

Key Facts

$2.29 billion
contract value awarded by U.S. Space Force
SpaceX
recipient of the military data network contract
U.S. Space Force
agency that issued the award

Transparency Panel

Sources cross-referenced5
Confidence score54%
Synthesized bySubstrate AI
Word count87 words
PublishedMay 27, 2026, 10:34 AM
Bias signals removed1 across 1 outlet
Signal Breakdown
Framing 1

Related Stories

WHO Director Visits Congo as Ebola Outbreak SpreadsNpr
science3 hrs ago

WHO Director Visits Congo as Ebola Outbreak Spreads

The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.

Npr
France 24
2 sources
Benzinga Publishes Article on Biotech Stocks During Pandemic Recoveryfinance.yahoo.com
science5 hrs agoDeveloping

Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery

Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…

Benzinga
1 source
FDA Panel Recommends XFG Variant for Fall Covid Shotsmedpagetoday.com
science1 hr agoDeveloping

FDA Panel Recommends XFG Variant for Fall Covid Shots

Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.

Stat
1 source